Actively Recruiting
Exposure to Organochlorine Pollutants and Impact on Development in the Peripubertal Age in Guadeloupe
Led by Centre Hospitalier Universitaire de la Guadeloupe · Updated on 2025-11-17
650
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire de la Guadeloupe
Lead Sponsor
I
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
In the context of environmental pollution of the French West Indies by chlordecone and questions about health consequences, monitoring at the peripubertal age of children born alive in the TIMOUN cohort is justified in several respects: - existence of an already established mother-child cohort whose live-born children will reach peripubertal ages during the period 2020-2022; - opportunity to verify hypotheses put forward on the basis of toxicological data acquired in laboratory animals and the hormonal characteristics of chlordecone (endocrine disruptor); - strong societal demand for such research to be carried out because of concerns about the sensitivity of children and adolescents to the effects of environmental xenobiotics, in particular on sexual development and the age of puberty; - recommendation of the Scientific Council Chlordecone Inserm - InVS; specific action of the National Plan Chlordecone IV.
CONDITIONS
Official Title
Exposure to Organochlorine Pollutants and Impact on Development in the Peripubertal Age in Guadeloupe
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be born to a mother whose pregnancy was included in the Timoun cohort (2004 - 2007) and whose parents agreed to be contacted later.
- Reside in Guadeloupe at the peripubertal age
- Have affiliation to a social security scheme
- Agree to participate in the study and provide informed consent if a minor
- Parents must agree to participate and sign informed consent
You will not qualify if you...
- Refusal to participate in the research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU of Guadeloupe
Pointe-à-Pitre, Guadeloupe, Guadeloupe, 97159
Actively Recruiting
Research Team
V
Valérie HAMONY-SOTER
CONTACT
E
Eunice NUBRET
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here